Amgen (AMGN) Research & Development (2009 - 2026)

Amgen's Research & Development history runs 18 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• In Q1 2026, Research & Development rose 15.68% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $7.5 billion (up 22.89% YoY), while the FY2025 annual figure was $7.3 billion, up 21.93% from the prior year.
• Research & Development was $1.7 billion for Q1 2026 at Amgen, down from $2.1 billion in the prior quarter.
• In the past five years, Research & Development ranged from a high of $2.1 billion in Q4 2025 to a low of $959.0 million in Q1 2022.
• Historically, Research & Development has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Research & Development decreased 21.8% in 2022, then surged 34.38% in 2024.
• A 5-year view of Research & Development shows it stood at $1.3 billion in 2022, then climbed by 15.86% to $1.5 billion in 2023, then climbed by 12.39% to $1.7 billion in 2024, then increased by 24.25% to $2.1 billion in 2025, then slipped by 19.75% to $1.7 billion in 2026.
• The last three Research & Development figures came in at $1.7 billion (Q1 2026), $2.1 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.